Specific estradiol biosynthetic pathway in choriocarcinoma (JEG-3) cell line

Journal of Steroid Biochemistry and Molecular Biology

Volumn 116, Issue 3-5, 2009, Pages 154-159

  Samson, Mélanie ^a   Labrie, Fernand ^a   Luu The, Van ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

DHEA; Estradiol; Estradiol biosynthesis; Inhibitor; JEG 3; Placenta; siRNA; Steroidogenesis

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; AROMATASE; ENZYME INHIBITOR; ESTRADIOL; MESSENGER RNA; PRASTERONE; SMALL INTERFERING RNA;

ANALYTIC METHOD; AROMATIZATION; ARTICLE; CANCER CELL CULTURE; CHORIOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

3-HYDROXYSTEROID DEHYDROGENASES; AROMATASE; CARBON RADIOISOTOPES; CELL LINE, TUMOR; CHORIOCARCINOMA; DEHYDROEPIANDROSTERONE; ESTRADIOL; ESTRADIOL DEHYDROGENASES; FEMALE; HUMANS; UTERINE NEOPLASMS;

EID: 67650649396     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.05.009     Document Type: Article

References (38)

1. Abdul-Karim R.W., Nesbitt Jr. R.E., Drucker M.H., and Rizk P.T. The regulatory effect of estrogens on fetal growth. I. Placental and fetal body weights. Am. J. Obstet. Gynecol. 109 4 (1971) 656-661
2. Lee Y.J., and Gorski J. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc. Natl. Acad. Sci. U.S.A. 93 26 (1996) 15180-15184
3. Sharma S.C., Kumari U., Dighe R.R., and Rao A.J. Regulation of protein synthesis in the first trimester human placenta by 17 beta-oestradiol and progesterone. Placenta 11 1 (1990) 63-74
4. Jiang S.W., Lloyd R.V., Jin L., and Eberhardt N.L. Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells. DNA Cell Biol. 16 8 (1997) 969-977
5. Albrecht E.D., and Pepe G.J. Placental steroid hormone biosynthesis in primate pregnancy. Endocr. Rev. 11 1 (1990) 124-150
6. Salido E.C., Yen P.H., Barajas L., and Shapiro L.J. Steroid sulfatase expression in human placenta: immunocytochemistry and in situ hybridization study. J. Clin. Endocrinol. Metab. 70 6 (1990) 1564-1567
7. Bonifas J.M., Morley B.J., Oakey R.E., Kan Y.W., and Epstein Jr. E.H. Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. Proc. Natl. Acad. Sci. U.S.A. 84 24 (1987) 9248-9251
8. Yen P.H., Allen E., Marsh B., Mohandas T., Wang N., Taggart R.T., and Shapiro L.J. Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange. Cell 49 4 (1987) 443-454
9. Luu-The V., Lachance Y., Labrie C., Leblanc G., Thomas J.L., Strickler R.C., and Labrie F. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Mol. Endocrinol. 3 8 (1989) 1310-1312
10. Luu-The V., Takahashi M., and Labrie F. Purification of microsomal and mitochondrial 3beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase from human placenta. Ann. N. Y. Acad. Sci. 595 (1990) 386-388
11. Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J., Cote J., Leblanc G., Lagace L., Berube D., et al. Purification, cloning, complementary DNA structure, and predicted amino acid sequence of human estradiol 17 beta-dehydrogenase. Ann. N. Y. Acad. Sci. 595 (1990) 40-52
12. Luu The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J., Leblanc G., Cote J., Berube D., Gagne R., et al. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Mol. Endocrinol. 3 8 (1989) 1301-1309
13. Fisher C.R., Graves K.H., Parlow A.F., and Simpson E.R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U.S.A. 95 12 (1998) 6965-6970
14. Miyaura C., Toda K., Inada M., Ohshiba T., Matsumoto C., Okada T., Ito M., Shizuta Y., and Ito A. Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280 4 (2001) 1062-1068
15. Oz O.K., Zerwekh J.E., Fisher C., Graves K., Nanu L., Millsaps R., and Simpson E.R. Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner. Res. 15 3 (2000) 507-514
16. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., and Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80 12 (1995) 3689-3698
17. Bilezikian J.P., Morishima A., Bell J., and Grumbach M.M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N. Engl. J. Med. 339 9 (1998) 599-603
18. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., and Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337 2 (1997) 91-95
19. 2O release from 1beta,2beta-3H-androgens. J. Biol. Chem. 251 6 (1976) 1625-1631
20. Kellis Jr. J.T., and Vickery L.E. Purification and characterization of human placental aromatase cytochrome P-450. J. Biol. Chem. 262 9 (1987) 4413-4420
21. Peltoketo H., Isomaa V., Maentausta O., and Vihko R. Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett. 239 1 (1988) 73-77
22. Luu-The V., Labrie C., Simard J., Lachance Y., Zhao H.-F., Couët J., Leblanc G., and Labrie F. Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol. Endocrinol. 4 2 (1990) 268-275
23. Krazeisen A., Breitling R., Imai K., Fritz S., Moller G., and Adamski J. Determination of cDNA, gene structure and chromosomal localization of the novel human 17beta-hydroxysteroid dehydrogenase type 7(1). FEBS Lett. 460 2 (1999) 373-379
24. Luu-The V., Tremblay P., and Labrie F. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 20 2 (2006) 437-443
25. Takahashi M., Luu-The V., and Labrie F. Inhibitory effect of synthetic progestins, 4-MA and cyanoketone on human placental 3 beta-hydroxysteroid dehydrogenase/5 → 4-ene-isomerase activity. J. Steroid Biochem. Mol. Biol. 37 2 (1990) 231-236
26. Brodie A.M., and Santen R.J. Aromatase and its inhibitors in breast cancer treatment-overview and perspective. Breast Cancer Res. Treat. 30 1 (1994) 1-6
27. Cadot C., Laplante Y., Kamal F., Luu-The V., and Poirier D. C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: chemical synthesis and biological evaluation. Bioorg. Med. Chem. 15 2 (2007) 714-726
28. Luu The V., Paquet N., Calvo E., and Cumps J. Improve real-time RT-PCR method for high throughput measurements using second derivative calculation and double correction. BioTechniques 32 2 (2005) 287-293
29. Nokelainen P., Peltoketo H., Vihko R., and Vihko P. Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol. Endocrinol. 12 7 (1998) 1048-1059
30. Han Q., Campbell R.L., Gangloff A., Huang Y.W., and Lin S.X. Dehydroepiandrosterone and dihydrotestosterone recognition by human estrogenic 17beta-hydroxysteroid dehydrogenase. C-18/c-19 steroid discrimination and enzyme-induced strain. J. Biol. Chem. 275 2 (2000) 1105-1111
31. Rhéaume E., Lachance Y., Zhao H.-F., Breton N., Dumont M., de Launoit Y., Trudel C., Luu-The V., Simard J., and Labrie F. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads. Mol. Endocrinol. 5 8 (1991) 1147-1157
32. Dumont M., Luu-The V., de Launoit Y., and Labrie F. Expression of human 17 beta-hydroxysteroid dehydrogenase in mammalian cells. J. Steroid Biochem. Mol. Biol. 41 3-8 (1992) 605-608
33. Dumont M., Luu-The V., Dupont E., Pelletier G., and Labrie F. Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J. Invest. Dermatol. 99 4 (1992) 415-421
34. Luu-The V., Pelletier G., and Labrie F. Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase. J. Steroid Biochem. Mol. Biol. 93 2-5 (2005) 269-276
35. Marijanovic Z., Laubner D., Moller G., Gege C., Husen B., Adamski J., and Breitling R. Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol. Endocrinol. 17 9 (2003) 1715-1725
36. Moon Y.A., and Horton J.D. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J. Biol. Chem. 278 9 (2003) 7335-7343
37. Rheaume E., Simard J., Morel Y., Mebarki F., Zachmann M., Forest M.G., New M.I., and Labrie F. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat. Genet. 1 4 (1992) 239-245
38. Laplante Y., Rancourt C., and Poirier D. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors. Mol. Cell. Endocrinol. 301 1-2 (2008) 146-153